Changes of bone turnover markers during perioperative anthracycline- and/or taxane-based chemotherapy in pre- and postmenopausal patients with primary breast cancer

被引：0
|
作者：
Kurbacher, C. M. [1 ]
Rauschenbach, N. [1 ]
Kurbacher, A. T. [1 ]
Sperling, S. [1 ]
Herz, S. [1 ]
Monreal, K. [1 ]
Kurbacher, J. A. [1 ]
机构：
[1] Gynecol Ctr Bonn Friedenspl, Bonn, Nrw, Germany
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P4-10-17
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-10-17
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Bevacizumab in Combination with Metronomic Chemotherapy in Patients with Anthracycline- and Taxane-Refractory Breast Cancer
    Garcia-Saenz, J. A.
    Martin, M.
    Calles, A.
    Bueno, C.
    Rodriguez, L.
    Bobokova, J.
    Custodio, A.
    Casado, A.
    Diaz-Rubio, E.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (05) : 632 - 639
  • [12] A pharmacophore-based classification better predicts the outcomes of HER2-negative breast cancer patients receiving the anthracycline- and/or taxane-based neoadjuvant chemotherapy
    Li, Xuan
    Sun, Hefen
    Liu, Qiqi
    Liu, Yang
    Hou, Yifeng
    Jin, Wei
    CANCER MEDICINE, 2021, 10 (13): : 4658 - 4674
  • [13] Changes in body composition and muscle attenuation during taxane-based chemotherapy in patients with metastatic breast cancer
    Rier, Hanah N.
    Jager, Agnes
    Sleijfer, Stefan
    van Rosmalen, Joost
    Kock, Marc C. J. M.
    Levin, Mark-David
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 95 - 105
  • [14] Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy
    Vasconcelos, Ines
    Wiesske, Alexandra
    Schoenegg, Winfried
    BREAST, 2018, 40 : 1 - 3
  • [15] Changes in body composition and muscle attenuation during taxane-based chemotherapy in patients with metastatic breast cancer
    Hánah N. Rier
    Agnes Jager
    Stefan Sleijfer
    Joost van Rosmalen
    Marc C. J. M. Kock
    Mark-David Levin
    Breast Cancer Research and Treatment, 2018, 168 : 95 - 105
  • [16] CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer
    Marme, Frederik
    Werft, Wiebke
    Walter, Anne
    Keller, Sascha
    Wang, Xiaoli
    Benner, Axel
    Burwinkel, Barbara
    Sinn, Peter
    Hug, Sarah
    Sohn, Christof
    Bretz, Niko
    Moldenhauer, Gerhard
    Rupp, Christian
    Rupp, Anne-Kathleen
    Biakhov, Mikhail Y.
    Bottini, Alberto
    Friedrichs, Kay
    Khailenko, V. A.
    Manikhas, Georgiy M.
    Ruiz, Amparo
    Sanchez-Rovira, Pedro
    Santoro, Armando
    Segui, Miguel A.
    Villena, Carlos
    Lichter, Peter
    Kristiansen, Glen
    Altevogt, Peter
    Schneeweiss, Andreas
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (03) : 819 - 831
  • [17] African American Women Who Receive Primary Anthracycline- and Taxane-Based Chemotherapy for Triple-Negative Breast Cancer Suffer Worse Outcomes Compared With White Women
    Balmanoukian, Ani
    Zhang, Zhe
    Jeter, Stacie
    Slater, Shannon
    Armstrong, Deborah K.
    Emens, Leisha A.
    Fetting, John H.
    Wolff, Antonio C.
    Davidson, Nancy E.
    Jacobs, Lisa
    Lange, Julie
    Tsangaris, Theodore N.
    Zellars, Richard
    Gabrielson, Edward
    Stearns, Vered
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (22) : E35 - E37
  • [18] Predictive value of CD24 ala/val polymorphism for pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer.
    Marme, F.
    Werft, W.
    Benner, A.
    Burwinkel, B.
    Sinn, H.
    Sohn, C.
    Lichter, P.
    Hahn, M.
    Altevogt, P.
    Schneeweiss, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [19] CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer
    Frederik Marmé
    Wiebke Werft
    Anne Walter
    Sascha Keller
    Xiaoli Wang
    Axel Benner
    Barbara Burwinkel
    Peter Sinn
    Sarah Hug
    Christof Sohn
    Niko Bretz
    Gerhard Moldenhauer
    Christian Rupp
    Anne-Kathleen Rupp
    Mikhail Y. Biakhov
    Alberto Bottini
    Kay Friedrichs
    V. A. Khailenko
    Georgiy M. Manikhas
    Amparo Ruiz
    Pedro Sánchez-Rovira
    Armando Santoro
    Miguel A. Segui
    Carlos Villena
    Peter Lichter
    Glen Kristiansen
    Peter Altevogt
    Andreas Schneeweiss
    Breast Cancer Research and Treatment, 2012, 132 : 819 - 831
  • [20] Body Composition, Adherence to Anthracycline and Taxane-Based Chemotherapy, and Survival After Nonmetastatic Breast Cancer
    Cespedes Feliciano, Elizabeth M.
    Chen, Wendy Y.
    Lee, Valerie
    Albers, Kathleen B.
    Prado, Carla M.
    Alexeeff, Stacey
    Xiao, Jingjie
    Shachar, Shlomit S.
    Caan, Bette J.
    JAMA ONCOLOGY, 2020, 6 (02) : 264 - 270
12345